Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note released on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Shares of NASDAQ:CALA opened at $0.00 on Friday. Calithera Biosciences has a 12-month low of $0.00 and a 12-month high of $0.12. The business has a 50 day moving average of $0.02 and a 200-day moving average of $0.02.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.